Quantcast

Latest Oncophage Stories

2014-10-14 04:22:05

TUBINGEN, Germany, October 14, 2014 /PRNewswire/ -- Regulatory authority approves clinical trial for Glioma Actively Personalized Vaccine Consortium (GAPVAC) First centers to enroll glioblastoma patients opened in Heidelberg and Tuebingen European Union supports the initiative with a EUR6 million grant immatics biotechnologies GmbH and BioNTech AG announce...

2014-04-28 08:31:24

DUBLIN, Apr. 28, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/85rshn/global) has announced the addition of the "Global Therapeutic Vaccines Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 A therapeutic vaccine is a biological combination developed to improve immunity by inducing an attack against a diseased cell or tissue. This differs from prophylactic vaccines, which are administered to an individual...

2008-11-13 15:00:06

Propelled by advances in molecular biology, the treatment of colorectal cancer is on the verge of dramatic change and a promising future as innovative vaccines will replace chemotherapy. According to a new report from Kalorama Information, "Cancer Vaccines: Market Forecasts, New Developments and Pipeline Analysis," this market, lead by OncoVAX, is poised for unprecedented growth, creating countless opportunities for market participants. More than 1.2 million cases of colon cancer are...

2008-11-05 09:00:34

Antigenics Inc. (NASDAQ: AGEN) reported results for the quarter ended September 30, 2008. The company incurred a net loss attributable to common stockholders of $11.1 million, or $0.17 per share, basic and diluted, for the third quarter of 2008, compared with a net loss attributable to common stockholders in the third quarter of 2007 of $11.0 million, or $0.24 per share, basic and diluted. For the nine months ended September 30, 2008, the company incurred a net loss attributable to common...

2008-11-04 06:00:00

Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue. Cancer Vaccines: Market Forecasts, New Developments and Pipeline Analysis http://www.reportlinker.com/p096701/Cancer-Vaccines-Market- Forecasts-New-Developments-and-Pipeline-Analysis.html (Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.) It is...

2008-11-03 09:00:39

Antigenics Inc. (NASDAQ: AGEN) today announced that Garo Armen, Ph.D., the company's chairman and chief executive officer, will present at the Rodman and Renshaw 10th Annual Healthcare Conference at the Palace Hotel in New York on Monday, November 10, 2008 at 12:25 p.m. Eastern Time. Dr. Armen will provide an overview of the company and its priority development programs, including Oncophage(R) (vitespen) therapeutic cancer vaccine and QS-21(TM) vaccine adjuvant. The audio portion of...

2008-10-23 12:00:26

Antigenics, a biotechnology company, has submitted a marketing authorization application to the European Medicines Agency requesting approval for Oncophage in earlier-stage, localized renal cell carcinoma under the conditional authorization provision. In advance of the marketing authorization application (MAA) submission, meetings with European Medicines Agency (EMEA) representatives, including the rapporteur countries, were convened to discuss the results from the international,...

2008-10-22 06:00:08

Antigenics Inc. (NASDAQ: AGEN) today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMEA) requesting approval for Oncophage(R) in earlier-stage, localized renal cell carcinoma (kidney cancer) under the conditional authorization provision. Currently, there are no EMEA-approved drug therapies for this patient population. "The creation of the EMEA's conditional approval regulation provides an important mechanism for allowing patients...

2008-09-30 09:01:00

Antigenics, a biotechnology company, has announced that the FDA has granted the necessary permission to allow for the export of Oncophage to Russia. The FDA export license clears the way to provide patients in Russia with Oncophage, which will continue to be manufactured at the company's facility in Lexington, Massachusetts. The Russian Ministry of Public Health approved the therapeutic cancer vaccine in April 2008 for the adjuvant treatment of kidney cancer patients at intermediate risk...

2008-09-29 12:00:14

Antigenics Inc. (NASDAQ: AGEN) today announced that the U.S. Food and Drug Administration (FDA) has granted the necessary permission to allow for the export of Oncophage (R) (vitespen) to Russia. The Russian Ministry of Public Health approved the therapeutic cancer vaccine in April 2008 for the adjuvant treatment of kidney cancer patients at intermediate risk for disease recurrence. The FDA export license clears the way to provide patients in Russia with Oncophage, which will continue to...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.